Intas Pharmaceuticals Limited — Capecitabine Exporter Profile
Indian Pharmaceutical Exporter · #5 for Capecitabine · $6.4M export value · DGFT Verified
Intas Pharmaceuticals Limited is the #5 Indian exporter of Capecitabine with $6.4M in export value and 200 verified shipments. Intas Pharmaceuticals Limited holds a 5.7% market share in Capecitabine exports across 18 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.
Intas Pharmaceuticals Limited — Capecitabine Export Profile: Buyers & Destinations
Where Does Intas Pharmaceuticals Limited Export Capecitabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| INDONESIA | $877.1K | 24 | 19.6% |
| HONG KONG | $730.6K | 44 | 16.3% |
| SOUTH AFRICA | $589.8K | 37 | 13.2% |
| UNITED KINGDOM | $402.6K | 9 | 9.0% |
| THAILAND | $348.1K | 8 | 7.8% |
| PERU | $291.2K | 16 | 6.5% |
| POLAND | $273.9K | 13 | 6.1% |
| NETHERLANDS | $257.1K | 12 | 5.7% |
| UNITED STATES | $214.2K | 22 | 4.8% |
| CANADA | $178.5K | 6 | 4.0% |
Intas Pharmaceuticals Limited exports Capecitabine to 21 countries. The largest destination is INDONESIA accounting for 19.6% of Intas Pharmaceuticals Limited's Capecitabine shipments, followed by HONG KONG (16.3%) and SOUTH AFRICA (13.2%). These destinations reflect Intas Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Capecitabine from Intas Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PT. KALBE FARMA TBK. | INDONESIA | $439.2K | 11 |
| TO THE ORDER | HONG KONG | $417.5K | 21 |
| THE SIAM COMMERCIAL BANK PUBLIC CO LTD | THAILAND | $348.1K | 8 |
| PT KALBE FARMA TBK JL LETJEN SOEPRAPTO KAV | INDONESIA | $276.1K | 6 |
| ACCORD HEALTHCARE C/O QESTMED | SOUTH AFRICA | $271.7K | 17 |
| ACCORD HEALTHCARE C/O QESTMED (PTY) | SOUTH AFRICA | $261.6K | 15 |
| ACCORD HEALTHCARE POLSKA SP Z O O | POLAND | $199.1K | 8 |
| ACCORD HEALTHCARE S.A.C | PERU | $197.1K | 8 |
| ACCORD HEALTHCARE LTD | UNITED KINGDOM | $195.2K | 10 |
| BANK OF CHINA (HONG KONG) LIMITED | HONG KONG | $180.8K | 12 |
Intas Pharmaceuticals Limited supplies Capecitabine to 37 buyers globally. The largest buyer is PT. KALBE FARMA TBK. (INDONESIA), followed by TO THE ORDER (HONG KONG) and THE SIAM COMMERCIAL BANK PUBLIC CO LTD (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Capecitabine Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?
India exported $32.0M worth of Capecitabine through 2,246 shipments from 216 suppliers to 123 countries, serving 516 buyers globally. Intas Pharmaceuticals Limited contributes $6.4M to this total, accounting for 5.7% of India's Capecitabine exports. Intas Pharmaceuticals Limited ships Capecitabine to 21 countries through 37 buyers.
What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Capecitabine Exports?
Intas Pharmaceuticals Limited's average Capecitabine shipment value is $31.9K per consignment, based on 200 shipments totaling $6.4M. The largest destination is INDONESIA (19.6% of Intas Pharmaceuticals Limited's Capecitabine exports).
How Does Intas Pharmaceuticals Limited Compare to Other Indian Capecitabine Exporters?
Intas Pharmaceuticals Limited ranks #5 among 216 Indian Capecitabine exporters with a 5.7% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($7.4M), INTAS PHARMACEUTICALS LIMITED ($5.0M), EUGIA PHARMA SPECIALITIES LIMITED ($4.0M). Intas Pharmaceuticals Limited processed 200 shipments to 18 destination countries.
What Capecitabine Formulations Does Intas Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL DRUGS AND MEDICINE : INTACAPE 500 Each film coated tablet contains : Capecitabine USP......500 mg Ne | $348.1K | 8 |
| PH.DRU.& MED: TACERAL 500MG TABLETS CAPECITABINE TABLETS 500MG EACH TABLET CONT. CAPECITABINE USP 500MG [12X10T PER PA | $226.1K | 5 |
| CAPECITABINE ACCORD 500 MG | $208.4K | 6 |
| PHAR.DRUGS AND MED: TACERAL CAPECIT 500MG 12X10T KALBE-INDO EACH FILM COATED TABLET CONTAINS: CAPECITABINE USP 500 MG | $162.8K | 4 |
| PHARMA DRUGS AND MEDI TACERAL CAPECIT 500MG 12X10T KALBE-INDO EACH FILM COATED TABLET CONTAINS: CAPECITABINE USP 500 MGTBS | $150.9K | 6 |
| CAPECITABINE 500MG 12X10TACCORD-PP-UK | $150.1K | 4 |
| CAPECITABINE 500MG 1X120T ACC-CANADA | $150.0K | 3 |
| CAPECITABINE 500MG 12X10T | $146.0K | 11 |
| PHARMACEUTICAL DRUGS & MEDICINE CAPEXA CAPECITABINE 500MG 12X10T(ACC-SA EACH FILM COATED TABLET CONTS:CAPECITABINE 500MGTBS | $120.5K | 6 |
| PHARMA DRUGS & MEDI CAPEXA CAPECITABINE500 MG 12X10T(ACC-SA AS PER INVOICE | $119.3K | 3 |
Intas Pharmaceuticals Limited exports 102 distinct Capecitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL DRUGS AND MEDICINE : INTACAPE 500 Each film with 8 shipments worth $348.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Capecitabine to Key Markets
What Intas Pharmaceuticals Limited must comply with to export Capecitabine to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Intas Pharmaceuticals Limited Compare to Nearest Capecitabine Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MSN LABORATORIES PRIVATE LIMITED | $7.4M | 323 | 8 | $23.0K |
| 5 | INTAS PHARMACEUTICALS LIMITED ★ | $5.0M | 200 | 18 | $25.1K |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED | $4.0M | 80 | 7 | $50.0K |
| 1 | MANKIND PHARMA LIMITED | $2.9M | 58 | 1 | $50.0K |
Intas Pharmaceuticals Limited ranks #5 among 216 Indian Capecitabine exporters. Average shipment value of $25.1K compared to the market average of $148.1K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.
Which Indian Ports Ship Capecitabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 359 | 16.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 283 | 12.6% |
| DELHI AIR CARGO ACC (INDEL4) | 233 | 10.4% |
| HYDERABAD ICD (INSNF6) | 173 | 7.7% |
| HYDERABAD AIR | 154 | 6.9% |
| DELHI AIR | 142 | 6.3% |
| HYDERABAD ACC (INHYD4) | 89 | 4.0% |
| Bombay Air | 80 | 3.6% |
What Other Advanced Oncology Products Does Intas Pharmaceuticals Limited Export?
Intas Pharmaceuticals Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Capecitabine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)
Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.
Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.
About Intas Pharmaceuticals Limited
Intas Pharmaceuticals Limited exports 75 products worth $372.3M. Beyond Capecitabine, top products include Ras, Mycophenolate, Tacrolimus, Apixaban, Ezetimibe. View the complete Intas Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Capecitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Capecitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 227 individual customs records matching Intas Pharmaceuticals Limited exporting Capecitabine, covering 102 formulations to 21 countries via 37 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Capecitabine Export Data from Intas Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Intas Pharmaceuticals Limited's Capecitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Intas Pharmaceuticals Limited
Full Company Profile →
75 products · $372.3M total trade · 19 categories
Capecitabine Stats
Company Overview
Top Products by Intas Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Intas Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Capecitabine. For current shipment-level data, contact TransData Nexus.